The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...

Ambroxol boosts levels of an enzyme called GCase, which is known to help clear away waste products which have gathered in brain cells. In Parkinson’s, a build up of a troublesome protein called ...

“Ambroxol was safe, well-tolerated, and demonstrated target engagement,” scientists wrote, however adding that the drug’s clinical effect on cognition was “not confirmed” in the study.

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with Parkinson's disease. The corresponding study was published in JAMA Neurology. People ...

Ambroxol was safe, well-tolerated and reached therapeutic levels in the brain. Psychiatric symptoms worsened in the placebo group but remained stable in those taking Ambroxol.

Abstract Ambroxol as a Treatment for Parkinson Disease Dementia A Randomized Clinical Trial Importance Carrying a variation in the gene for β-glucocerebrosidase is a major risk factor for Parkinson ...